ArticleJournal of orthopaedic case reports2026
Outcomes of Surgical Treatment for Masada Type lVa Forearm Deformity in Children with Multiple Hereditary Exostosis: A Case Series.
Article in Journal of orthopaedic case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Multiple hereditary exostosis (MHE) is a rare autosomal dominant skeletal disorder widely known as multiple osteochondromatosis that frequently affects the growing ends of long bones. It causes multiple progressive deformities, especially in the wrist, elbow, knee and ankle. The spectrum of features in the forearm includes deformities due to growth arrest of the distal ulnar physis, an increase in the negative ulnar variance, excess radial bowing, an increased radial articular angle, with or without radial head dislocation and restricted pronosupination. Masada's classification applies to forearm deformity in MHE, where Type IVa deformity includes distal osteochondromas of both radius and ulna with ulnar shortening without radial head subluxation or dislocation. It warrants timely surgical intervention to prevent progressive deformity, radial head dislocation and irreversible articular damage. Aim: The aim of the study was to report the clinical and radiological outcomes of single-stage surgical intervention for Masada Type IVa forearm deformity in children with MHE. Materials and Methods: Retrospective study of three children with Masada 4 A forearm deformity due to MHE was included in the study. Their mean age was 12.7 years, and they all underwent single stage Ulnar osteochondroma resection, proximal ulnar corticotomy, and gradual ulnar lengthening by distraction osteogenesis using an LRS (Limb reconstruction system) external fixator. All three cases had periodic follow-up with a mean of 27.5 months. Results: All patients showed high negative ulnar variance needing ulnar distraction lengthening in addition to ulnar osteochondroma excision. Mean ulnar lengthening achieved was 3.6 cm (range: 2.3-4.3 cm). The bowed radius with a mean magnitude of 1.5 in all these cases had a normal range of bow percentage, but with a high radio-capitular articulation inclination angle. High Radio-articular angle of 36° with open physis warranted radial growth modulation in one of the cases, in addition to redo distraction lengthening of the ulna. Conclusion: Single-stage surgical correction combining distal ulnar osteochondroma excision with Ulnar lengthening by distraction osteogenesis is safe and reproducible for Masada Type IVa deformity in growing children that prevents radial head dislocation. Early intervention confers the greatest benefit of a normal elbow joint in addition to deformity correction that is consistent in radiological and its functional gains.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.